T1	Participants 65 164	metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial.
T2	Participants 336 389	metabolically obese, normal-weight (MONW) individuals
T3	Participants 401 449	total of 47 MONW individuals with hypomagnesemia
T4	Participants 1636 1652	MONW individuals
